Detalhe da pesquisa
1.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
N Engl J Med
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820078
2.
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
Mod Pathol
; 37(2): 100406, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104892
3.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
4.
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year results from DASCERN.
Haematologica
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695123
5.
The interaction between social determinants of health and cervical cancer survival: A systematic review.
Gynecol Oncol
; 181: 141-154, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38163384
6.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood
; 138(21): 2031-2041, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407542
7.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
8.
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
N Engl J Med
; 381(24): 2315-2326, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826340
9.
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.
Future Oncol
; 18(38): 4161-4170, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36524980
10.
Social needs and health-related quality of life among hematologic cancer survivors.
Support Care Cancer
; 30(11): 8919-8925, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895158
11.
Knowledge of prostate cancer among African American men: A systematic review.
Prostate
; 81(3): 202-213, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368465
12.
Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib.
Cancer
; 127(15): 2641-2647, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823073
13.
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.
Cancer
; 127(11): 1894-1900, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449377
14.
BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study.
Cancer
; 127(8): 1246-1259, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270904
15.
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome.
Br J Haematol
; 195(3): 378-387, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340254
16.
Impact of luteinizing hormone suppression on hematopoietic recovery after intensive chemotherapy in patients with leukemia.
Haematologica
; 106(4): 1097-1105, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33297667
17.
A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome.
Haematologica
; 106(8): 2121-2130, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853292
18.
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
Ann Hematol
; 100(5): 1181-1194, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740113
19.
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.
Eur J Haematol
; 106(6): 808-820, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638218
20.
Determination of fitness and therapeutic options in older patients with acute myeloid leukemia.
Am J Hematol
; 96(4): 493-507, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368536